Marchex

Score breakdown

Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.

Marchex is a useful option for dental service organizations and healthcare groups that need to understand why callers do or do not book. Marketing staff can trace inquiries to campaigns, while operations managers can examine conversations and coach individual offices. Patient Prism is a genuine alternative for this appointment-conversion job. CallRail overlaps on attribution, but should not be assumed to replace every patient-specific recovery workflow.

This is a configured business analytics purchase, with the scope shaped by locations, call volumes, and the required integrations. Its value is strongest when an organization has enough inbound calls and management capacity to turn findings into changed front-desk behavior. A small practice that only wants to count advertising calls may need a simpler product.

• Outcomes and workflow value (7.8): PDS Health accounts connect the analytics to concrete patient-call and office-performance work.
• Product and service depth (8.1): Call attribution, summaries, sentiment, and conversion analysis address several parts of the appointment journey.
• Ease of implementation (7.1): Number configuration, integrations, and coaching processes require implementation; published review summaries also report setup and reporting friction.
• Pricing clarity (6.3): Healthcare pricing is supplied through sales, making the full multi-location cost harder to compare in advance.

How Patient Calls Become Useful Evidence

Marchex connects call sources with conversation analysis so a group can distinguish a marketing problem from an appointment-handling problem. Summaries help managers find insurance questions, patient frustration, and communication issues without listening to every recording. Conversion analysis helps show where an inquiry failed to become scheduled care.

The healthcare offering includes dental, health and wellness, and senior-living use cases. Those markets share phone-based inquiries, but they have different booking processes. A dental deployment should use dental examples, call categories, and appointment definitions when checking whether the analysis is useful.

What the Deployment Evidence Supports

PDS Health marketing staff describe using summaries to locate issues and office-level recommendations to understand weak performance. These are relevant healthcare references because they concern actual call analysis across offices. They support workflow usefulness without establishing a universal percentage increase in appointments.

The software can identify a missed opportunity, but a practice still needs a person to make the follow-up call, correct a process, or train staff. Analytics alone does not create appointment capacity, resolve insurance coverage, or replace a scheduling team. The practical result depends on the response after the report.

Implementation and Reporting Tradeoffs

A rollout needs working call routing, reliable attribution, appropriate access to recordings, and a clear connection to the organization’s appointment definitions. Healthcare buyers should include privacy requirements and recording practices in the agreement. Existing phone and marketing systems affect the amount of integration work.

The G2 comparison summarizes reports of setup confusion, reporting discrepancies, and limited integrations alongside positive support feedback. That is a useful reason to test the intended reports and connections before expanding a deployment.

Product and service details: marchex.com, g2.com.

Company scale

Marchex reported $45.420 million in GAAP revenue for 2025. Its March 2026 announcement also described an approximately $60 million annualized potential combined run rate with Archenia. Scale source

What People Say

What people like

"The call summaries are really helpful for pinpointing where issues start."

PDS Health

"Office-level recommendations would help us decide where coaching is needed."

What people don't like

"We need to test the reporting and integrations before moving every location over."

Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.

Based on: Product or service details, Product or service details.

Competitor landscape

Pricing

Recent news

• November 2026: Marchex reported third-quarter 2026 revenue of $16.0 million, up from $15.2 million a year earlier, and net income of $1.3 million. It also appointed Travis Fairchild, the former CEO of Archenia, as president, effective November 9, 2026.
• July 2026: Marchex completed its acquisition of Archenia, a customer qualification and acquisition company, after stockholders approved the deal on July 1, 2026.